Robert T. Keenan, MD, MPH, MBA

Arthrosi Therapeutics
Chapel Hill, NC, United States

Dr. Keenan has published several peer reviewed articles and book chapters on gout and uveitis.

Presentation(s):

• 0244: Efficacy and Safety of AR882, a Selective Uric Acid Transporter 1 (URAT1) Inhibitor, in Gout Patients with Various Baseline Characteristics Following 12-Week Treatment in Patients

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• L15: AR882, an Efficacious and Selective URAT1 Inhibitor for Patients with Chronic Gouty Arthritis and Subcutaneous Tophi: Results from a Global, Prospective, Proof-of-Concept Trial Using Dual Energy Computed Tomography

  Wednesday, November 15, 2023
  7:30 AM – 7:45 AM PT

  Disclosure information not submitted.